Consonance Capital Management as of Dec. 31, 2020
Portfolio Holdings for Consonance Capital Management
Consonance Capital Management holds 38 positions in its portfolio as reported in the December 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| United Therapeutics Corporation (UTHR) | 7.5 | $80M | 529k | 151.79 | |
| Iovance Biotherapeutics (IOVA) | 7.4 | $79M | 1.7M | 46.40 | |
| Mirati Therapeutics | 6.8 | $73M | 330k | 219.64 | |
| Tcr2 Therapeutics Inc cs | 6.7 | $71M | 585k | 121.85 | |
| Atara Biotherapeutics | 6.5 | $69M | 3.5M | 19.63 | |
| GenMark Diagnostics | 6.1 | $65M | 4.5M | 14.60 | |
| Springworks Therapeutics (SWTX) | 6.1 | $65M | 894k | 72.52 | |
| Globus Med Cl A (GMED) | 5.5 | $59M | 909k | 65.22 | |
| Protagonist Therapeutics (PTGX) | 5.1 | $55M | 2.7M | 20.16 | |
| Macrogenics (MGNX) | 4.9 | $53M | 2.3M | 22.86 | |
| Keros Therapeutics (KROS) | 3.7 | $39M | 557k | 70.54 | |
| Mersana Therapeutics (MRSN) | 3.5 | $37M | 1.4M | 26.61 | |
| Arvinas Ord (ARVN) | 3.4 | $36M | 425k | 84.93 | |
| Kadmon Hldgs | 2.8 | $31M | 7.3M | 4.15 | |
| Deciphera Pharmaceuticals | 2.6 | $28M | 485k | 57.07 | |
| Gamida Cell SHS | 2.6 | $28M | 3.3M | 8.39 | |
| Agios Pharmaceuticals (AGIO) | 2.6 | $27M | 631k | 43.33 | |
| ImmunoGen | 2.1 | $23M | 3.5M | 6.45 | |
| Casi Pharmaceuticalsinc Com Stk | 2.1 | $22M | 7.6M | 2.95 | |
| Verastem | 1.5 | $17M | 7.8M | 2.13 | |
| Iveric Bio | 1.5 | $16M | 2.4M | 6.91 | |
| Stereotaxis Com New (STXS) | 1.5 | $16M | 3.1M | 5.09 | |
| Assembly Biosciences | 1.1 | $12M | 2.0M | 6.05 | |
| Consonance Hfw Acquisition C Unit 99/99/9999 | 1.0 | $11M | 1.0M | 10.47 | |
| Arcus Biosciences Incorporated (RCUS) | 0.9 | $10M | 388k | 25.96 | |
| Sio Gene Therapies Common | 0.8 | $8.9M | 3.2M | 2.78 | |
| Cellectar Biosciences Com Par | 0.8 | $8.5M | 4.1M | 2.08 | |
| Cti Biopharma | 0.8 | $8.1M | 2.5M | 3.22 | |
| Cogent Biosciences (COGT) | 0.6 | $6.8M | 610k | 11.23 | |
| Deerfield Healthcare Tech Ac Unit 07/16/2025 | 0.4 | $3.8M | 250k | 15.00 | |
| Jiya Acquisition Corp Com Cl A | 0.3 | $3.1M | 300k | 10.30 | |
| Adma Biologics (ADMA) | 0.3 | $3.0M | 1.6M | 1.95 | |
| Bctg Acquisition Corp | 0.2 | $2.1M | 180k | 11.44 | |
| Helix Acquisition Corp Com Cl A | 0.2 | $1.7M | 150k | 11.23 | |
| Fs Dev Corp Com Cl A | 0.1 | $1.1M | 100k | 11.00 | |
| Actinium Pharmaceuticals (ATNM) | 0.1 | $690k | 88k | 7.80 | |
| Cerevel Therapeutics Hldng I (CERE) | 0.1 | $658k | 40k | 16.58 | |
| Y Mabs Therapeutics (YMAB) | 0.0 | $301k | 6.1k | 49.56 |
